GlassScriptPhysician profile
Kartick Patel
NPI 1174938112
$6,936.04
in general payments reported to CMS, 2019-2025
32 companies · $1,201 in 2025
The $1,201 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,448 · 2020: $368 · 2021: $621 · 2022: $980 · 2023: $850 · 2024: $1,468 · 2025: $1,201.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,520.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,520.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paragon 28, INC. | $1,589.56 | 2019-2022 | |
| Smith+Nephew, INC. | $786.77 | 2020-2025 | Renasys Touch, Renasys Go V2 Home, Pico 7 |
| Paratek Pharmaceuticals, INC. | $706.46 | 2021-2025 | Nuzyra |
| Stryker Corporation | $654.15 | 2020-2025 | Prostep Mica, Prophecy, Biofoam |
| Ani Pharmaceuticals, INC. | $603.82 | 2024-2025 | Purified Cortrophin Gel |
| Organogenesis INC. | $523.28 | 2021-2025 | Apligraf, Puraply Wound Matrix, Affinity |
| Horizon Therapeutics Plc | $481.99 | 2021-2023 | Krystexxa |
| Nevro Corp. | $328.41 | 2022-2024 | Senza |
| Melinta Therapeutics, LLC | $180.50 | 2022-2023 | Kimyrsa |
| Amgen INC. | $177.62 | 2024-2025 | Krystexxa |
| Medtronic, INC. | $146.92 | 2022-2025 | Inceptiv |
| Abbott Laboratories | $130.59 | 2025 | Eterna |
| Dynasplint Systems INC. | $103.04 | 2019-2025 | Dynasplint |
| Baudax Bio INC. | $100.00 | 2022 | |
| Biotissue Holdings INC. | $87.12 | 2024 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $33.79 | 2023 | |
| Orthofix Medical, INC. | $33.38 | 2019-2022 | |
| Access Pro Medical, LLC | $28.10 | 2025 | Matriderm |
| Stability Biologics, LLC | $25.28 | 2022 | |
| Mimedx Group, INC. | $21.38 | 2025 | |
| Averitas Pharma INC. | $20.60 | 2024 | Qutenza |
| Alfasigma USA, INC. | $19.59 | 2021 | |
| Inari Medical, INC. | $18.75 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Kowa Pharmaceuticals America, INC. | $18.37 | 2023 | Seglentis |
| Nabriva Therapeutics, Plc | $18.27 | 2021 | |
| Sebela Pharmaceuticals INC. | $16.18 | 2023 | Naftin, Pramosone |
| Cdc Medical LLC | $15.71 | 2022 | |
| Convatec INC. | $14.67 | 2023 | |
| Osiris Therapeutics INC. | $14.18 | 2019 | |
| Zyla Life Sciences, INC. | $13.75 | 2020 | |
| Cashflow Solutions, LLC | $13.49 | 2025 | Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White, Pcd-52 737a (US) White |
| Biocomposites INC | $10.32 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kartick Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.